Related Experiment Video
Updated: Mar 25, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Updates on the Pharmacologic Treatment of Individuals with Human Immunodeficiency Virus
1Vanderbilt University School of Nursing, 461 21st Avenue South, Nashville, TN 37240, USA.
Abstract:
Human immunodeficiency virus has been affecting the human population for more than 30 years. During this time period, more effective, safe, simple, and tolerable pharmacologic agents have been developed. To date, there are 26 antiretroviral agents available that are used either as a single agent or a coformulation in an antiretroviral regimen. The goal of these medications is to achieve viral suppression in individuals infected with human immunodeficiency virus. Evidence continues to support the most effective combinations. It is important that clinicians are knowledgeable of updates so as to provide the best possible medical regimen for this population.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Drug Excretion

